drugset / Trial / NCT01560390

Use of Ketamine Associate With an Opioid for Sedation in ICU

NCT01560390 ↗

Phase 4 Completed 164 enrolled University Hospital, Clermont-Ferrand
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of the study is to evaluate the impact of ketamine associated to an opioid for sedation of mechanically ventilated critically ill patients versus placebo. Sedation will be drive by nurses according to an algorithm. The investigators will evaluate the quantity of opioates used in each arm and the safety of ketamine.

Timeline

Start
2011-10
Primary completion
2012-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.15 mg/kg Other
Background Remifentanil Small molecule — —

Indications

No indication recorded.